Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Fluctuating income requires a budget that adapts. This guide shows how to structure Zero Based Budgeting to handle peaks and troughs.
19,826 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A federal court in Tennessee blocked state enforcement actions against Kalshi, citing a likelihood the contracts may ...
Looking to squeeze more value from every swipe? This credit card rewards guide breaks down how rewards work, how to p...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...
Adobe faces a dynamic year as AI competition and enterprise spending shape the adobe (adbe) stock price. This report ...
A U.S. senator opens inquiry into Binance after reports that more than $1 billion routed to Iranian-linked entities r...
Fox Factory's Q4 2025 results shed light on demand for high-performance suspensions and the company’s margin discipli...
OpenAI is in talks with the U.S. Department of Defense on a potential AI services contract, with safeguards and deplo...
Analysts are shifting their stance on Palantir, suggesting upside potential after a period of mixed momentum. This gu...
As Archer Aviation moves toward broader commercial programs, investors need a clear view of 2025 earnings drivers. Th...
Investors are buzzing about a potential silver surge. This guide breaks down the chances of american silver going $70...